Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early‐stage oral tongue cancer

Alhadi Almangush, Ibrahim O. Bello, Harri Keski–Säntti, +13

Head & Neck

For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality

Alhadi Almangush, Ibrahim O. Bello, Ricardo D. Coletta, +15

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Oral Potentially Malignant DisordersMedicineCancer RecurrenceOral CavityPathology +7

A simple novel prognostic model for early stage oral tongue cancer

Alhadi Almangush, Ricardo D. Coletta, Ibrahim O. Bello, +16

International Journal of Oral and Maxillofacial Surgery

Oral Potentially Malignant DisordersMedicineOral CavityPathologyOncology +4

Isolated Sphenoid Sinus Diseases

Pirkko Ruoppi, Juha Seppä, Matti Pukkila, +1

Archives of Otolaryngology - Head and Neck Surgery

Prognostic impact of tumour–stroma ratio in early‐stage oral tongue cancers

Alhadi Almangush, Ilkka Heikkinen, Nassira Bakhti, +13

Histopathology

CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma

Ari Kosunen, Risto Pirinen, Kirsi Ropponen, +9

Oral Oncology

OncologyCd44 ExpressionMedicineImmunologyClinicopathological Factors +7

Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma

Ari Kosunen, Kirsi Ropponen, Jari Kellokoski, +9

Oral Oncology

Poor SurvivalMedicineOral CavityOral BiologyPathology +7

High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma

Matti Pukkila, Ari Kosunen, Kirsi Ropponen, +7

Journal of Clinical Pathology

Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma

Petri Koivunen, Leif Bäck, Matti Pukkila, +4

The Laryngoscope

Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression

Anna Jouppila‐Mättö, Mervi Närkiö‐Mäkelä, Ylermi Soini, +5

BMC Cancer